Dizon DS - Search Results

1

Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.

Hall TR, Dizon DS. Hall TR, et al. Among authors: dizon ds. Clin Adv Hematol Oncol. 2016 Apr;14(4):262-8. Clin Adv Hematol Oncol. 2016. PMID: 27166608 Review.

2

Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.

Dizon DS, Hensley ML, Poynor EA, Sabbatini P, Aghajanian C, Hummer A, Venkatraman E, Spriggs DR. Dizon DS, et al. J Clin Oncol. 2002 Mar 1;20(5):1238-47. doi: 10.1200/JCO.2002.20.5.1238. J Clin Oncol. 2002. PMID: 11870166

3

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, Spriggs D. Dizon DS, et al. Gynecol Oncol. 2003 Dec;91(3):584-90. doi: 10.1016/j.ygyno.2003.08.017. Gynecol Oncol. 2003. PMID: 14675681

4

For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?

Dizon DS, Restivo A, Lomme M, Charbonneau N, Brard L, Hughes T, Weitzen S, Legare R, Granai CO, Disilvestro P. Dizon DS, et al. Am J Clin Oncol. 2008 Feb;31(1):39-42. doi: 10.1097/COC.0b013e318134ee6f. Am J Clin Oncol. 2008. PMID: 18376226

5

Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.

Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM. Penson RT, et al. Among authors: dizon ds. J Clin Oncol. 2010 Jan 1;28(1):154-9. doi: 10.1200/JCO.2009.22.7900. Epub 2009 Nov 16. J Clin Oncol. 2010. PMID: 19917843 Clinical Trial.

6

Where do antiangiogenic agents belong in the treatment algorithm for ovarian cancer?

Dizon DS. Dizon DS. Am J Clin Oncol. 2013 Oct;36(5):519-25. doi: 10.1097/COC.0b013e318216e699. Am J Clin Oncol. 2013. PMID: 21552100 Review.

7

Advances in the management of recurrent endometrial cancer.

Bradford LS, Rauh-Hain JA, Schorge J, Birrer MJ, Dizon DS. Bradford LS, et al. Among authors: dizon ds. Am J Clin Oncol. 2015 Apr;38(2):206-12. doi: 10.1097/COC.0b013e31829a2974. Am J Clin Oncol. 2015. PMID: 23764681 Review.

8

Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.

Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Rauh-Hain JA, et al. Among authors: dizon ds. Int J Gynecol Cancer. 2013 Sep;23(7):1219-25. doi: 10.1097/IGC.0b013e31829f17c9. Int J Gynecol Cancer. 2013. PMID: 23975042

9

Ovarian cancer: genomic analysis.

Wei W, Dizon D, Vathipadiekal V, Birrer MJ. Wei W, et al. Ann Oncol. 2013 Dec;24 Suppl 10(Suppl 10):x7-15. doi: 10.1093/annonc/mdt462. Ann Oncol. 2013. PMID: 24265410 Free PMC article. Review.

10

The effects of age on treatment and outcomes in women with stages IB1-IIB cervical cancer.

Roque DR, Cronin B, Robison K, Lopes V, Rizack T, Dizon DS. Roque DR, et al. Among authors: dizon ds. J Geriatr Oncol. 2013 Oct;4(4):374-81. doi: 10.1016/j.jgo.2013.07.002. Epub 2013 Aug 8. J Geriatr Oncol. 2013. PMID: 24472482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page